A heart insufficiency treated by glucocorticoids;Une insuffisance cardiaque traitée par glucocorticoïdes

Praxis

Volumn 96, Issue 42, 2007, Pages 1643-1647

  Froidevaux, L ^a   Levotanec, I ^b   Waeber, G ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY INSTITUTE OF PATHOLOGY   (Switzerland)

Author keywords

Cardiac arrhythmia; Cardiac sarcoidosis; Glucorticoids; Heart failure; Myocardial biopsy

Indexed keywords

EID: 35448939683     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: 10.1024/1661-8157.96.42.1643     Document Type: Article

References (14)

1. Chapelon-Abric C et al. Cardiac sarcoidosis: a retrospective study of 41 cases. Medicine (Baltimore) 2004 Nov;83(6):315-34. (Pubitemid 39541109)
2. Iwai, K, Sekiguti, M, Hosoda, Y, et al. Racial difference in cardiac sarcoidosis incidence observed at autopsy. Sarcoidosis 1994; 11:26.
3. Thomsen,TK, Eriksson, T.Myocardial sarcoidosis in forensic medicine. Am J Forensic Med Pathol 1999; 20:52.
4. Uemura A, Morimoto S, Hiramitsu S, et al. Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies.Am Heart J 1999;138:299-302. (Pubitemid 29379681)
5. Fields CL et al. Thalium-201 scintigraphy in the diagnosis and management of myocardial sarcoidosis. South Med J 1990;83:339-42 (Pubitemid 20108642)
6. OkayamaK et al. Diagnostic and prognostic value of myocardial scintigraphy with thalium-201 and gallium-67 in cardiac sarcoidosis. Chest 1995;107:330-4
7. Okumura W, Iwasaki T, Toyama T, et al. Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis. J Nucl Med 2004;45:1989-98. A direct comparison of the usefulness of 18F-FDG PET, technetium-99m, and gallium-67 SPECT in detecting lesions of cardiac sarcoidosis.
8. Vignaux O, Dhote R, Duboc D, et al. Detection of myocardial involvement in patients with sarcoidosis applying T2-weighted, contrast-enhanced, and cine magnetic resonance imaging: initial results of a prospective study. J Comput Assist Tomogr 2002;26:762-7. (Pubitemid 35423381)
9. Roberts WC, McAllister HA Jr, Ferrans VJ. Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11). Am J Med 1977;63:86-108. (Pubitemid 8146656)
10. Fleming HA, Bailey SM.The prognosis of sarcoid heart disease in the United Kingdom. Ann N Y Acad Sci 1986;465:543-50. (Pubitemid 16006594)
11. Okura Y, Dec GW, Hare JM, et al. A clinical and histopathologic comparison of cardiac sarcoidosis and idiopathic giant cell myocarditis. J Am Coll Cardiol 2003;41:322-9.
12. Chapelon-Abric, C, de Zuttere, D, Duhaut, P, et al. Cardiac Sarcoidosis: A Retrospective Study of 41 Cases. Medicine (Baltimore) 2004; 83:315.
13. Winters SL, Cohen M, Greenberg S, et al. Sustained ventricular tachycardia associated with sarcoidosis: assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device. J Am Coll Cardiol 1991;18:937-43.
14. Oni AA, Hershberger RE, Norman DJ, et al. Recurrence of sarcoidosis in a cardiac allograft: control with augmented corticosteroids. J Heart Lung Transplant 1992;11:367-9.